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The terminal RNA regions of the genomic and antigenomic RNAs of the paramyxoviruses and rhabdoviruses are known
to contain sequences essential for directing RNA replication and transcription. The 39 terminus (leader region) of the
negative-sense, genomic RNA of the rhabdoviruses and paramyxoviruses is known as the leader (Le) promoter and directs
synthesis of positive-sense replication and transcription products. The 39 terminus of the antigenome is termed the trailer
complementary (TrC) promoter and directs the synthesis of genomic RNA. By creating mutations in the corresponding
regions of an HPIV3 minireplicon in which the viral protein coding sequences were replaced by the luciferase gene, we were
able to precisely define the elements of the leader promoter involved in directing positive-strand replication of HPIV3.
Nucleotides 1 through 12 (from the terminus) formed a domain critical for replication. The region from nucleotides 13 through
55 was important but not crucial for replication, while G residues at positions 79, 85, and 91 comprised another domain
critical for replication. It was also shown that the TrC promoter is similar, though not identical, to the Le promoter.
Nucleotides 1 through 12 of the TrC promoter were critical for synthesis of genomic RNA, though specific positions behaved
differently from the corresponding positions of the Le promoter. While many of these mutations could not be analyzed for
transcription because they completely abrogated genomic RNA synthesis (the template for transcription), we were surprised
to find that no mutations in the leader promoter which decreased replication had any significant effect on transcription.
However, mutations in the intergenic sequence and gene start signal following the leader and preceding the luciferase
message severely decreased transcription, but not replication. © 2000 Academic PressINTRODUCTION
Human parainfluenza virus type 3 (HPIV3) is an impor-
tant cause of lower respiratory tract infections in infants
for which no effective antiviral treatments or vaccines
are available, although candidate vaccines are being
developed (Belshe and Hissom, 1982; Belshe et al.,1992;
Karron et al.,1995; Ray et al.,1995; Collins et al.,1996a;
kiadopoulos et al., 1998). HPIV3 is an enveloped, single-
tranded, negative-strand RNA virus of 15,462 nucleo-
ides and a member of the respirovirus genus within the
amily Paramyxoviridae. The basic replication scheme of
PIV3 is similar to that of other members of the Para-
yxoviridae and the closely related Rhabdoviridae (Col-
lins et al.,1996a).
The replication cycle of HPIV3 begins with attachment
to cell surface receptors and fusion of the viral envelope
with the cell membrane. This allows release of the viral
ribonucleoprotein (RNP) into the cytoplasm. The RNP is
the central unit for viral transcription and replication and
contains viral RNA tightly encapsidated by the nucleo-
capsid protein (N), a complex termed the N-RNA which
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Virology, The Lerner Research Institute,
C20, Cleveland Clinic Foundation, Cleveland, Ohio 44195-5001. Fax:
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201serves as the template for both transcription and repli-
cation. The viral phosphoprotein (P), large polymerase
protein (L), and specific host proteins are associated
with the RNP and required for transcription and replica-
tion (Collins et al.,1996a). Transcription, the first RNA
synthetic event after entry of the RNP into the cytoplasm,
is believed to initiate at the 39 end of the genome RNA
and proceeds via a sequential start-stop mechanism to
produce a 52-nucleotide leader RNA followed in turn by
the six viral mRNAs. Transcription initiation and termina-
tion on each gene is mediated by conserved sequences
termed gene start and gene stop, which are found at the
beginning and end of each gene, respectively. Following
the initial transcription phase, the genomic RNP must be
replicated. Like transcription, this RNA synthesis initiates
at the 39 end of the genomic RNA. However, during
replication the nascent RNA is encapsidated and the
gene stop and gene start signals are ignored, so that the
entire genome RNA is copied into a positive-sense rep-
lication product called the antigenome. The region at the
39 end of the genome involved in synthesis of the anti-
genomic RNA is termed the leader (Le) promoter. Simi-
larly, the 39 end of the antigenome then serves as a
replication promoter (trailer complementary [TrC] pro-
moter) for synthesis of genomic RNA.Recently, the development of reverse-genetics sys-
tems for the rhabdoviruses and paramyxoviruses has
0042-6822/00 $35.00
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202 HOFFMAN AND BANERJEEprovided valuable new tools to investigate in more detail
the roles of the cis-acting RNA elements involved in
replication and transcription. In these systems, a plas-
mid-derived RNA containing the viral 59 and 39 terminal
regions can be replicated in cells in which the viral
replication proteins are also expressed. For the rhab-
doviruses and most of the paramyxoviruses (except hu-
man respiratory syncytial virus [RSV], which requires one
additional protein [Collins et al.,1996b]) the N, P, and L
proteins are sufficient to promote efficient viral replica-
tion and transcription. Much of what we know about
HPIV3 replication comes from study of Sendai virus
(SeV), the prototypical paramyxovirus.
One surprising discovery made with SeV is the “rule of
six,” so-called. Using SeV minireplicons, Calain and Roux
(1993) demonstrated that the length of the replicating
RNA must be a multiple of 6 to be replicated. This has
been interpreted as a need for the nucleocapsid protein
to bind exactly 6 nucleotides to form the functional tem-
plate for replication. The rule of six has since been
confirmed for HPIV3 and is probably true for all
paramyxoviruses, except RSV (Samal and Collins, 1996;
Durbin et al.,1997; Murphy and Parks, 1997; Kolakofsky et
al.,1998).
The replication promoters have also been mapped for
SeV. Nucleotides 1–31 appear to have a major role in
promoting replication (Tapparel and Roux, 1996). A sec-
ond domain has also been shown to be involved in
replication. This was first shown for simian virus 5 (SV5),
a member of the rubulavirus genus of the paramyxovi-
ruses, and has since been shown for SeV (Murphy et
al.,1998; Tapparel et al.,1998; Murphy and Parks, 1999).
With SeV the second domain appears to consist of three
N protein binding sites, comprising bases 79–84, 85–90,
and 91–96. Within each hexamer the first base must be a
G, while the remaining five bases can vary. Therefore,
only positions 79, 85, and 91 appear to be critical. One
HPIV3 minireplicon containing 97 leader-terminal and 91
trailer-terminal nucleotides was able to replicate and
transcribe, confirming that these RNA regions contain
the cis elements necessary for HPIV3 replication and
transcription (De and Banerjee, 1993).
We wanted to examine the terminal sequences of
HPIV3 genomic and antigenomic RNA and their possible
role in transcription and replication more thoroughly. To
this end we created a HPIV3 minireplicon and made
single-base substitution mutations in the leader and
trailer complementary promoter regions.
RESULTS
Characterization of the HPIV3 minireplicon
T7 RNA polymerase transcription of the minireplicon
pHPIV3-MG(2) results in expression of an analog of the
HPIV3 genome RNA (Fig. 1C). This plasmid contains a T7
promoter which directs the synthesis of 91 nucleotidesfrom the 59 terminus of the HPIV3 genome, a negative-
sense copy of the luciferase gene, and 97 nucleotides
from the 39 terminus of the genome. The hepatitis delta
virus antigenomic ribozyme follows and effects precise
cleavage after the 39 terminal HPIV3-specific nucleotide.
Encoded in the HPIV3-specific terminal sequences are
all the cis-acting elements required for efficient replica-
ion and transcription. Within the 39 terminal HPIV3 seg-
ent is the leader sequence, the NP gene start signal
nd part of the 59 nontranslated region of the N mRNA
Fig. 1A). The 59 terminal HPIV3 sequence encodes part
f the L mRNA 39 nontranslated region, the L gene stop
ignal, and the trailer region (Fig. 1B). The minigenome
NA length is 1854 nucleotides and thus conforms to the
ule of six.
Transfection of pHPIV3-MG(2) and plasmids encoding
he HPIV3 N, P, and L proteins into HeLa cells infected
ith a recombinant vaccinia virus which expresses T7
NA polymerase resulted in replication and transcription
f the minigenome RNA. Under optimal conditions (0.2
FIG. 1. (A) The 39 terminus of the genome. This sequence shown
serves as the promoter for transcription and synthesis of the anti-
genome and is termed the leader promoter. (B) The 39 terminus of the
antigenome. This region is designated the trailer complementary pro-
moter and serves as the promoter for synthesis of the genome. (C)
Structure of the HPIV3 minireplicon, pHPIV3-MG(2). Transcription from
the plasmid is directed by a T7 RNA polyerase promoter (T7). The
primary transcript is negative sense and contains two nonviral Gs,
followed by sequence encoding the viral trailer (tr), a gene end signal
(GE), part of the L gene 39 NTR, the luciferase gene, part of the N gene
59 NTR, a gene start signal (GS), the viral leader (le), the hepatitis delta
virus ribozyme (Rz), and a T7 RNA polymerase transcription termination
signal (T7f).mg pHPIV3-MG(2), 0.64 mg pPIV3-N, 0.7 mg pPIV3-P, and
0.1 mg pPIV3-L) luciferase expression was amplified 200-
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203ROLE OF TERMINAL RNA SEQUENCES OF HPIV3fold over background (without L) levels. All three support
plasmids were required for this expression. Additionally,
we tested one mutant which disrupted conformity to the
rule of six. A single base insertion within the region
encoding the N 59 NTR resulted in luciferase expression
t 5% of wild-type levels (data not shown). Such an effect
as seen previously with a similar HPIV3 minireplicon
Durbin et al.,1997).
utations within the leader and trailer
omplementary promoters
To define the RNA regions involved in promoting tran-
cription and positive-strand replication we started by
utating the first 16 positions of the leader promoter,
hanging each base to its complementary nucleotide.
or example, le5 denotes a change of nucleotide 5 from
he leader terminus from an A to a U in the positive
ense. Additional mutations were created in the leader
egion and within the region encoding the N mRNA 59
ontranslated region. In this latter region we mutated all
s to Cs since three Gs (in the positive sense) in this
egion of Sendai virus were previously shown to be
ritical for replication. This panel of mutants was as-
ayed for luciferase activity. Since optimal transcription
evels are dependent on replication, a defect in either
ranscription or replication should result in decreased
uciferase expression. Generally, mutations within the
irst 12 nucleotides were extremely severe, reducing lu-
iferase activity to 1–3% of wt levels (Fig. 2A). Mutants
e4, le5, and le10 were less severe, lowering luciferase
xpression to 12, 43, and 61% of wt levels, respectively.
utations in the 13–52 region were moderate or had no
ffect with luciferase expression ranging from 43–125%
f wt levels (Fig. 2A). Mutations in the 76–91 region fell
nto two classes (Fig. 2B). Those mutations correspond-
ng to the three critical G residues of Sendai were se-
ere, with activity of 25% for le79 and 1–2% for le85 and
e91. This correlates with data from Sendai virus in which
hose same positions were critical for replication. How-
ver, in Sendai a mutation of positions 79 through 84,
hich should correspond to our le79 mutation, com-
letely abrogated replication (Tapparel et al.,1998). Other
utations (le76, le80, le90) in this region had little effect
n luciferase expression.
We also made mutations within the terminal region of
he TrC promoter to compare with the leader mutations in
he critical 1–12 domain of the Le promoter (Fig. 2C).
ithin the TrC promoter even numbered bases (counting
rom the terminus) were mutated and designated trXX,
here XX denotes the nucleotide position from the ter-
inus. Additionally, trailer position 5 was mutated be-
ause the corresponding position of the leader exhibited
nusual activity. As was the case with the leader muta-ions (Fig. 2A), trailer mutations in the first 12 positions
ere highly detrimental for luciferase expression, whichwas decreased to 3–12% of wt levels (Fig. 2C). Similar to
the leader sequence, the trailer position 5 mutation had
good activity (93%). However, the tr10 mutation was in-
active, unlike the le10 mutation. Since the 17 terminal
nucleotides are identical in their respective Le and TrC
promoter senses, this difference in activity is surprising.
It appears that sequences within the replication promot-
ers (911 nucleotides) but outside the terminal 17 nucle-
otides must have some influence on the differential ac-
tivity of the terminal 17 nucleotides.
Analysis of RNA transcription
Because the luciferase assay was an indirect measure
of transcription and replication we analyzed the RNAs
synthesized during minigenome replication. Total RNA
was isolated from cells transfected as described earlier
and plus-strand RNA synthesis was measured using a
primer extension assay as described under Materials
and Methods. The primer used anneals to the positive-
sense luciferase coding sequence at the initiating AUG
codon. This primer thus anneals to the luciferase-con-
taining transcription product and the antigenomic repli-
cation product. The extension reaction was done with
Moloney murine leukemia virus reverse-transcriptase for
1 h at 42°C.
Extension products which correspond to the expected
transcription and replication positions are readily appar-
ent (Fig. 3). The transcription-extension products showed
some heterogeneity in size, with the major products
corresponding to the first two positions (11 and 12) of
the gene start sequence. This heterogeneity may be the
result of 59 terminal methylation of the transcription prod-
ucts. VSV transcription products have been shown to be
methylated at the 11 and 12 positions, and ribose
methylation has been shown to inhibit reverse transcrip-
tion (Abraham et al.,1975; Hagenbuchle et al.,1978; You-
van and Hearst, 1981). We believe this methylation may
also occur with HPIV3 transcription and causes the het-
erogeneity seen in the primer extension assay. As can be
seen in Fig. 3 and in Table 1, the amount of transcription
as measured by primer extension correlated with lucif-
erase activity. Thus, for these mutants luciferase expres-
sion accurately reflects transcription activity.
Analysis of RNA replication
The amount of replication measured by primer exten-
sion of total RNA was 5–10% of the transcription
amounts. However, analysis of the positive-sense repli-
cation products was somewhat difficult because of the
low intensity of the bands relative to background. We
also tried to assay minus-strand synthesis using total
RNA extracts. In this case the T7-directed transcription
product from the minigenome plasmid, which contains
two nonviral Gs at the 59 end, was very abundant and
obscured the visualization of the replicated negative-
h supp
ults ar
204 HOFFMAN AND BANERJEEstrand RNA, in which the two terminal Gs were lost
during HPIV3-directed replication. To solve both these
problems we treated cytoplasmic extracts with micrococ-
cal nuclease. This treatment results in digestion of un-
encapsidated RNAs (T7 and HPIV3-directed transcripts),
while encapsidated RNAs (replication products) remain
FIG. 2. Expression of luciferase by minigenomes containing leader
recombinant vaccinia virus (MVA), which expresses T7 RNA polymerase
at the indicated positions were transfected into HeLa cells along wit
prepared 28 h posttransfection and assayed for luciferase activity. Resintact. After RNA isolation from this extract, primer ex-
tension was performed as described previously for thepositive-sense replication product. The negative strand
was analyzed using AMV reverse-transcriptase at 52°C
and primer which anneals 101 nucleotides from the end
of the replicated negative-strand RNA.
The micrococcal nuclease treatment worked as ex-
pected. The transcription products were digested com-
59 NTR (B), and trailer (C) mutations. One hour after infection with a
ids derived from pHPIV3-MG(2) and containing single-base mutations
ort plasmids encoding the HPIV3 N, P, and L proteins. Lysates were
e shown relative to the wild-type plasmid, pHPIV3-MG(2).(A), N
, plasmpletely (data not shown), while the replication products
were resistant to micrococcal nuclease digestion (Fig. 4).
transcri
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205ROLE OF TERMINAL RNA SEQUENCES OF HPIV3However, despite this treatment a background band
which comigrated with the positive-sense replication
band (Figs. 4A and 4B, wt [-L]) was apparent. The inten-
sity of this background was approximately 5% of that
obtained with the wild-type minigenome. The primer exten-
sion for the negative-sense replication product did not pro-
duce any such background (Figs. 4A and 4B, wt [-L]).
This analysis mirrored the luciferase analysis in that
leader mutations in the 1–12 region were severe, those
in the 13–52 region were moderate, and those at posi-
FIG. 3. Primer extension analysis of the (A) leader and (B) trailer comp
Materials and Methods and total RNA was extracted 28 h posttransfec
using a negative-sense primer, which anneals within the luciferase co
ladder was made using the same primer and pHPIV3-MG(2) as the te
condensed by the removal of the region between the replication and
TABLE 1
Comparison between Luciferase and Primer
Extension Assay Resultsa
Mutation Luciferase Transcription by PEb
le2 2 5
le5 43 46
le8 1 1
le10 61 42
le14 80 75
le23 55 68
le35 90 71
le48 46 62
le79 29 34
le90 98 77
le91 2 2
tr4 10 17
tr5 96 91
tr10 3 7
tr14 65 87
a The luciferase activity of select mutants shown in Fig. 2 is displayed
s a percentage of that expressed by the wild-type clone pMG(2). The
rimer extension products corresponding to the transcription bands in
ig. 3 and other gels (not shown) were quantitated by phosphorimager
nalysis. Averages of at least two experiments for each mutant are
hown as a percentage of the extension products derived from
MG(2). Standard deviations for the primer extension quantitations
verage 613%.
b PE 5 primer extension.tions 79, 85, and 91 were severe (Fig. 4A). Several addi-
tional interesting observations were made from these
results. First, mutations le2, le3, le8, and le12 were able
to produce antigenomic RNA above background levels,
yet these mutations did not allow production of progeny
negative-sense RNA. It is interesting that mutations in
the Le promoter could prevent replication from the TrC
promoter. Perhaps these mutants were replicated but
encapsidated in an N-RNA form which could not be used
as a template for further replication. For example, the
Sendai virus nucleocapsid is known to exist in several
helical states, but perhaps only one state can be used as
a template for replication (Egelman et al.,1989). The lack
of genomic-sense replication products explains why
these mutants were not transcribed.
Second, it was surprising that the amount of transcrip-
tion relative to the amount of the template for transcrip-
tion (negative-sense RNA) was not decreased substan-
tially for any of these mutations (Table 2). For example,
the le5 mutation results in 31% minus-strand synthesis
relative to wild-type, yet transcription is still 43% of wild-
type. If this mutation was transcriptionally defective we
would have expected transcription to be significantly
below 31%. It is important to note that these calculations
were not possible for many of the mutants because
no negative-strand synthesis was detectable. Thus,
based on mutations with partial replication activity from
throughout the Le promoter, no region of the Le promoter
was clearly required for promoting transcription.
Third, by analyzing both the positive- and negative-
sense replication products for those mutants which had
at least moderate effects (,60% positive-strand synthe-
sis) we observed that the Le promoter mutations seem to
decrease positive-strand synthesis relative to negative-
strand synthesis (Fig. 4A, Table 2). This is not surprising
since these mutations are in the Le promoter and should
ary promoter mutations. Plasmids were transfected as described under
imer extension was done as described under Materials and Methods
gion, priming synthesis at the initiating AUG. The dideoxy sequencing
. Relevant regions of the sequence are denoted. The figure has been
ption-extension products.lement
tion. Pr
ding re
mplatehave their primary effect on antigenome synthesis. How-
ever, the effect was slight and therefore may not be
d
q
206 HOFFMAN AND BANERJEEsignificant. Despite this, examination of the TrC pro-
moter mutations seems to confirm this promoter-specific
inhibition.
The mutations in the TrC promoter act similarly to
those in the Le promoter. In the case of the Le promoter
mutations, the synthesis of negative-sense RNA is de-
creased relative to positive-sense RNA. For example,
mutants tr4 and tr5 reduce negative-strand synthesis to 6
and 55% of wild-type, respectively, while positive-strand
synthesis for these mutants was 32 and 120%, respec-
tively (Fig. 4B, Table 2). Additionally, TrC promoter muta-
tions (tr2, 4, 5, and 14) do not appear to significantly
decrease transcription (Table 2). This is as expected,
since these mutations are far removed from the site of
transcription initiation.
Analysis of leader/N gene junction mutations
Since we were surprised to find that no TrC promoter
mutations significantly decreased transcription, we cre-
ated additional mutations at the leader/N gene junction.
Each of these mutants has multiple substitutions as
FIG. 4. Primer extension analysis of micrococcal nuclease-treated ex
and Fig. 2. After 28 h the cells were lysed and the extracts treated with m
transfection was then purified, divided in two, and each half used in pr
products.The primer used for detection of the positive-sense replication
for detection of the negative-sense replication product anneals within
dideoxy sequencing ladders were made using these primers and pHP
Transcription-extension products are not shown because the microc
promoter mutations are shown in (A), and trailer complementary promot
erived from separate primer extension reactions and were analyzed
uantitated by phosphorimager analysis and are shown in Table 2.shown in Fig. 5A. Mutant KO-leend changes 3 bases at
the end of the leader sequence, while KO-int changes the3 bases of the intergenic signal (nt 53–55) and KO-Ngs
changes 5 of the 11 bases in the N gene start signal.
Positive-sense RNA synthesis from these mutants was
analyzed by primer extension of total RNA extracts. As
shown in Fig. 5B, the KO-leend mutation had little effect
on either transcription or replication while the KO-int and
KO-Ngs mutants almost completely abrogated transcrip-
tion. Replication of KO-int is 36% of wild-type and thus is
similar to many mutations in the nt 13–48 region. The
KO-Ngs mutant replicated at 171% of wild-type levels, yet
transcription was absent. Obviously, this region (nt 53–
66) is very different from the rest of the Le promoter in
that it is critical for transcription.
DISCUSSION
A number of factors are known to be involved in the
transcription and replication of HPIV3 RNA. The HPIV3 N,
P, and L proteins are required, along with host proteins
(De et al.,1993, 1996; Lamb and Kolakofsky, 1996). The
genome length must be a multiple of 6 and contain the 91
terminal leader and trailer nucleotides (Calain and Roux,
Plasmids were transfected as described under Materials and Methods
ccal nuclease to digest nonencapsidated RNAs. The RNA from a given
xtension assays to detect the positive- and negative-sense replication
ct was the same as that used in Fig. 3. The positive-sense primer used
ciferase coding region, priming synthesis within the stop codon. The
(2) as the template. Relevant regions of the sequences are denoted.
nuclease digested these nonencapsidated transcript RNAs. Leader
tions in (B). Note that the 1replication and 2replication products were
parate gels. The replication bands from these gels and others weretracts.
icroco
imer e
produ
the lu
IV3-MG
occal
er muta
on se1993; Tapparel et al.,1998). Here, by mutational analysis
we have more precisely defined the terminal RNA se-
207ROLE OF TERMINAL RNA SEQUENCES OF HPIV3quences and their structural roles in replication and
transcription.
It is apparent from the results that the terminal 12
nucleotides of both the leader and trailer are critical for
RNA replication (Figs. 1, 2A, and 2C). This correlates with
observations made from a sequence alignment of vi-
ruses closely related to HPIV3 within the respirovirus
subgroup of the paramyxovirus family. The sequence
alignment shows that the terminal 12 nucleotides of
these viruses are highly conserved (Fig. 6). Trailer posi-
tion 5 of SeV was the only promoter position which varied
in this region among these viruses. This correlates with
our data in which the le5 and tr5 mutations were not
severely disruptive. By extending the sequence compar-
ison to the morbiliviruses, it can be noted that within the
TABLE 2
Summary of Mutant Activities
Mutant 1Replicationa 2Replicationa Transcriptionb
Relative
transcriptionc
le1 0 0 1
le2 18 0 4
le3 9 0 2
le4 11 18 13 72
le5 21 31 45 145
le6 0 0 1
le7 0 0 1
le8 12 0 1
le9 0 0 1
le10 25 32 52 163
le11 0 0 2
le12 15 0 1
le13 86 140 89 157
le27 33 47 53 114
le48 111 103 54 52
le79 52 47 32 68
le85 0 0 2
le90 79 62 88 142
le91 0 0 2
tr2 15 10 6 60
tr4 32 5 13 260
tr5 120 55 93 170
tr6 10 0 5
tr8 12 0 3
tr10 14 0 5
tr12 13 0 3
tr14 139 114 74 67
a The positive- and negative-sense replication products were deter-
mined as described in Fig. 4 for select mutants and are displayed as a
percentage of the replication of the wild-type clone.
b Both luciferase assays (Fig. 2) and primer extension assays (Fig. 3)
were used to determine the transcription as a percentage of the
wild-type clone.
c The relative transcription was determined by dividing the amount of
transcription product by the amount of negative-sense replication prod-
uct, and is displayed as a percentage of the transcription efficiency of
the wild-type clone.terminal 12 nucleotides, positions 5, 10, and 11 are not
conserved (Fig. 6). This mirrors our results in whichmutations at positions 5 and 10 of the leader sequence
and 5 of the trailer sequence could be tolerated without
severe consequences. We did find, however, that a mu-
tation at leader position 11 abrogated positive-strand
replication. This position may be a species-specific de-
terminant of replication.
The finding that it is 12 nucleotides that are critical is
intriguing in light of the rule of six. This region may be
important as a nucleation site for encapsidation of the
nascent replication product. Evidence in our lab has
suggested that the N protein can form a soluble dimer
(Bishnu De, personal communication). Since the N pro-
tein is thought to bind 6 nucleotides, the 1–12 region may
represent the nucleation site for encapsidation by N
dimers. Alternatively, the terminal 12 nucleotides may be
the location at which the viral polymerase interacts with
the template RNA (or N-RNA). Of course, this region
could be important in both processes, since polymerase
binding would occur on the template and encapsidation
on the nascent transcript.
FIG. 5. Analysis of leader/N gene start junction mutations. (A) Three
mutations at the leader/N gene start junction are shown. The dots indicate
the positions changed in each mutant. (B) Primer extension analysis of the
leader/N gene start gene junction mutations. Plasmids were transfected
as described under Materials and Methods and total RNA was extracted
28 h posttransfection. Primer extension was done as described under
Materials and Methods using a negative-sense primer, which anneals
within the luciferase coding region, priming synthesis at the initiating AUG.
The figure has been condensed by the removal of the region between the
replication and transcription-extension products. The percentage positive-
strand replication and transcription relative to the wild-type clone are also
shown. These numbers are averages calculated from this autoradiogram
and one other experiment.
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208 HOFFMAN AND BANERJEEIn the present work we have found that leader nucle-
otides 13 through 55 of HPIV3 are involved in replication.
We propose that bases 13 through 55 constitute an RNA
domain that is important, but not critical, for the replica-
tion of HPIV3. This domain could be important as a
binding region for proteins (either viral or host) which
assist polymerase binding to the critical terminal 1–12
and/or the 79–91 domain. Alternatively, this region could
be involved in the proper alignment of the 1–12 and
79–91 domains. Previous studies with Sendai virus have
suggested that the N RNA forms a coiled structure, with
13 N proteins per turn(Egelman et al.,1989). If this is true,
the 1–12 domain and the 79–91 domain would be adja-
cent in the three-dimensional coiled structure. Mutations
in the 13–55 region could alter the spacing and/or three-
dimensional structure of the N-RNA, thereby reducing
replication efficiency. To further define and test the im-
portance of this region we will make larger substitution
mutations, changing 6–7 consecutive bases for the
length of this element.
Additional evidence suggests that the terminal 12 nu-
cleotides interact with the 13–55 and/or 79–91 regions. A
mutation at position 10 of the leader and trailer comple-
mentary promoters resulted in dramatically different rep-
lication phenotypes, despite the promoters’ being iden-
tical in their terminal 17 nucleotides (Fig. 2). The le10
mutation (Le promoter) had slightly reduced replication
while the equivalent mutation in the TrC promoter (tr10)
replicated very poorly. This indicates that sequences
outside the terminal 17 nucleotides must have significant
influence on the activity of the terminal region.
We have also shown that three G residues at positions
79, 85, and 91 of the Le promoter are critical for synthesis
FIG. 6. Sequence comparison of the terminal 24 bases from the
ntigenomic and genomic promoters of the respirovirus and morbilli-
irus genera of the paramyxoviruses. The sequence shown is of the
romoter sense (39 to 59). Bases which diverge from the HPIV3 se-
quence are shown in bold.of the HPIV3 antigenomic RNA. Through primer exten-
sion analysis we have shown that mutations at positions85 and 91 completely abrogated antigenome synthesis,
but the mutation at position 79 still allows some synthe-
sis of antigenomic RNA. In contrast, with Sendai virus no
differences were detected in the importance of the three
positions, as mutations in all three abrogated replication,
indicating that differences do exist between the HPIV3
and Sendai virus replication promoters (Tapparel et
al.,1998). Still, the basic function of this RNA domain is
probably conserved between these viruses. The 79, 85,
and 91 positions of the Sendai virus replication promoter
were previously postulated to be critical bases in three
consecutive N binding hexamers (Tapparel et al.,1998).
The G residues at 79, 85, and 91 constitute the first base
in each of three consecutive N binding hexamers, such
that the motif would be (GNNNNN)3. It has been specu-
lated that this region of Sendai virus may serve as a
nucleation site for encapsidation of the RNA by the N
protein (Tapparel et al.,1998). While this is certainly a
plausible explanation, it is not entirely consistent with
other observations. Mainly, the HPIV3 N protein does not
appear to exist as a soluble trimer, but as a soluble dimer
(Bishnu De, personal communication). Therefore, if bind-
ing of an N dimer initiates encapsidation, it is unclear
why the nucleation site would consist of three N protein
binding sites. An alternative explanation may be gleaned
from the fact that the N-RNA structure is capable of
forming a helix, with 13 N molecules per turn of the helix
(Egelman et al.,1989). This would mean that nucleotides
1–12 (N binding sites 1 and 2) would lie adjacent to
nucleotides 79–90 (N binding sites 14 and 15) and there-
fore may form a single recognition site for binding of the
replicase complex.
To summarize, it appears that three RNA regions,
bases 1–12, 13–55, and 79–91 are involved in promoting
replication of the respiroviruses. The 1–12 and 13–55
domains may be similar to the replication promoter of
VSV. In VSV, bases 1–24 of the replication promoter have
been shown to be critical for replication, while bases
25–45 were also important, but not critical (Li and Patt-
naik, 1997). It remains to be shown whether the critical
and important domains of the two virus types are func-
tionally analogous.
The promoter for transcription is more difficult to de-
fine. Despite having mutants with partial replication ac-
tivity in all three domains of the Le promoter, no de-
crease in transcription was detected for any of these
mutants when transcription was measured relative to
synthesis of the negative-sense replication product.
Thus, initially it may appear that none of these three
regions involved in replication is involved in promoting
transcription. However, there are numerous Le promoter
mutations which did not allow production of significant
levels of the negative-sense replication product. It re-
mains possible that these positions in the 1–12 and
79–91 domains, which completely abrogated replication,
could also be important for transcription. Ideally, the
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system similar to those created for vesicular stomatitis
virus and respiratory syncytial virus (Juhasz et al.,1999; Li
and Pattnaik, 1999; Peeples and Collins, 2000). In these
minigenome systems a mutation is located in the trailer,
which prevents synthesis of progeny genomic-sense
RNA. By preventing a full cycle of replication only posi-
tive-sense replication and transcription products are pro-
duced and transcription is no longer dependent on rep-
lication, making transcriptional analysis of antigenomic
promoter mutations possible. We have considered this
approach with HPIV3 but it does not appear to be feasi-
ble. With our most severe TrC promoter mutations (tr10,
for example) we were able to detect low levels of posi-
tive-sense replication products, but no transcription
products. In summary, it appears that with respect to the
three RNA domains involved in promoting antigenome
synthesis, only the critical 1–12 and 79–91 domains may
have any role in promoting transcription. Thus, if these
regions are involved in promoting transcription, the tran-
scription promoter lies entirely within the most critical
domains of the replication promoter. This is in contrast
with findings with VSV in which there are regions (nt
25–50) that are clearly more important in transcription
than replication (Li and Pattnaik, 1999; Whelan and Wertz,
1999).
The intergenic sequence and the N gene start signal
found between the leader region and the N gene was the
only region that, when mutated, disrupted transcription
more severely than replication. While this can be ex-
plained by stating that the intergenic junction and N gene
start signal are required for transcription initiation once
leader synthesis terminates, we believe that this region
could be considered part of the transcription promoter.
One reason for this consideration is that the presence of
this intergenic sequence/N gene start signal appears to
be the most obvious distinction between the Le and TrC
regions and could therefore be the reason transcription
occurs from the leader end of the genome and not the
trailer complementary end of the antigenome. In fact, the
proximity of the leader/N junction to two regions critical
in promoting replication may be what distinguishes pro-
moters for transcription from those for replication. In light
of recent findings which have shown that the VSV viral
replicase and transcriptase complexes appear to be dif-
ferent, it is certainly conceivable that the respective pro-
moters are also different (Richardson and Peluso, 1996;
Chuang and Perrault, 1997; Das et al.,1997). Further ex-
periments will examine the role of this region in promot-
ing transcription.
Future analysis of leader and trailer mutations in the
context of infectious HPIV3 may also prove informative.
By inserting leader and trailer mutation into the HPIV3
infectious clone and recovering virus, we would expect
to observe a correlation between the activity of a given
mutation (as assayed in this study) and the ability of avirus carrying this mutation to replicate. A virus with
reduced replicative ability could be tested for attenuation
and development as a vaccine candidate. Additionally, a
slow-growing virus may be able to revert. While this is
not desirable for vaccine purposes, mapping of second-
site reversion mutations may provide clues to the inter-
actions between the cis-acting replication elements and
viral proteins.
MATERIALS AND METHODS
Plasmid construction. The negative-sense minirepli-
con, pPIV3-MG(2), was constructed by modifying the
construct pHPIV3-CAT described in De and Banerjee
(1993). pHPIV3-CAT was designed as a plasmid from
which RNA could be transcribed in vitro and transfected
into cells and replicated by helper virus. This plasmid
was modified for use in a vaccinia virus T7-expression
system. A hepatitis delta virus antigenomic ribozyme
(HDV Rz) was inserted at the 39 end of the T7-derived,
genomic-sense replicon RNA. A PCR product encoding
the ribozyme was produced by the primers 59-ATTTTAA-
TTTAAATTTATATTTCCGAACAAGTTTCTTCTCTTGTTTGG-
TGGGTCGGCATGGCATCTC-39 and 59-CTGGGTACCTC-
CCTTAGCCATCCGAGT-39. The first primer encodes a
sequence from the HPIV3 leader, which includes a nat-
ural SwaI site and primes synthesis of the ribozyme
(underline). The second primer contains a KpnI site and
also primes synthesis on the ribozyme (underline). The
template for this PCR was pSA1 (Perrotta and Been,
1991). The ribozyme-containing PCR product was cloned
into pHPIV3-CAT by exchange of a SwaI/KpnI fragment. A
firefly luciferase reporter gene was then inserted into the
XbaI and PstI sites of pHPIV3-CAT, replacing the CAT
gene. To prevent interference by transcription from cryp-
tic vaccinia virus promoters, a vaccinia virus polymerase
transcription stop signal (TTTTTNT) was inserted just
upstream of the luciferase-encoding region at viral base
97 through PCR-directed mutagenesis. The replicon se-
quences were then transferred from the pUC19 back-
ground to pOCUS-2 to match the background of a previ-
ously described positive-sense minireplicon, pHPIV3-
MG(1) (Hoffman and Banerjee, 1997). The replicon
containing sequences were transferred by digesting
pHPIV3-CAT with PvuII and SspI and inserting the frag-
ment into the same sites of pOCUS-2. A T7 transcription
termination signal was then removed from pET-17b by
digestion with BlpI and BspEI and inserted into the PvuII
site of pOCUS-2. Finally, to increase transcription from
the minireplicon, two Gs were inserted adjacent to the T7
promoter via PCR-directed mutagenesis.
Mutations in pHPIV3-MG(2) were made by PCR-di-
rected mutagenesis. Mutations in the leader region were
made using primers which encoded a natural SwaI site
(bases 36 through 43) and the desired mutations. For
mutations in the 1–35 region the second PCR primer was
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products were digested with SwaI and BstXI and in-
serted into the same sites of pHPIV3-MG(2). For muta-
tions in the 44–91 region the second primer annealed at
base 659 of the luciferase sequence. These PCR prod-
ucts were cloned into pHPIV3-MG(2) through exchange
of SwaI/EcoRI fragments. Trailer region mutations were
made using one primer which encoded a HindIII site, the
T7 promoter, and the desired mutation, and another
which primed at base 1291 of firefly luciferase. The PCR
products derived thereby were digested with EcoRV and
HindIII and inserted into the same sites of pHPIV3-
MG(2).
Luciferase assay. HeLa cell monolayers were grown
on 12-well plates to 90% confluency and infected with
recombinant vaccinia virus MVA (Wyatt et al.,1995), which
expresses T7 RNA polymerase, at a multiplicity of infec-
tion of 3. After 1 h at 37°C the minireplicon and support
plasmids were transfected using lipofectin (Bethesda
Research Laboratories, Gaithersburg, MD) according to
manufacturer’s instructions. The plasmid amounts used
were: 200 ng pPIV3-MG(2), 640 ng pPIV3-N, 700 ng
pPIV3-P (which does not express the C protein), and 100
ng pPIV3-L. After 4 h the transfection medium was re-
moved and replaced with 1 ml of Dulbecco’s modified
Eagle’s medium–5% fetal calf serum. At 28 h posttrans-
fection the monolayers were lysed in 150 ml lysis buffer
rom which 1.5 ml lysate (equivalent to 2.3 3 103 cells)
ere then used to determine luciferase activity in a
ynatech ML2250 luminometer according to manufac-
urer’s specifications (Luciferase Assay Kit, Roche Bio-
hemicals, Indianapolis, IN).
RNA analysis. HeLa cells were transfected as de-
cribed earlier, except 6-well plates were used and all
aterial amounts were increased proportionately. For
xtraction of total RNA the cells were lysed and RNA
urified with RNA STAT-60 (Tel-Test, Friendswood, TX)
ccording to manufacturer’s specifications. For isolation
f replication-specific RNA the cells were lysed and the
onencapsidated RNA was digested with micrococcal
uclease as described by Durbin et al. (1997), and then
xtracted with RNA STAT-60.
Primer extension analysis of the positive-sense tran-
cription and replication products was done using a
egative-sense, [g-32P]ATP end-labeled oligomer, which
primes at nucleotide 2 of the luciferase gene. This primer
was used in a standard reverse-transcription reaction
with Moloney murine leukemia virus (MMLV) reverse-
transcriptase (Roche Biochemicals) at 42°C. Primer ex-
tension analysis of the negative-sense replication prod-
uct was done using an end-labeled oligomer that primes
at nucleotide 1649 of the luciferase gene, which is 101
nucleotides from the 59 end of the genomic RNA. This
primer extension was done using avian myoblastosis
virus (AMV) reverse-transcriptase at 52°C in a standard
reaction. The extension products were separated on a6% acrylamide/7 M urea gel and analyzed by autoradiog-
raphy and quantitation on a Molecular Dynamics Phos-
phorImager (Molecular Dynamics, Sunnyvale, CA).
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